Adenosine Receptor Inhibitors

Adenosine A₁ receptor (A₁R)

Adenosine A_2A receptor (A_2AR)

Adenosine A_2B receptor (A_2BR)

Adenosine A₃ receptor (A₃R)

Adenosine Receptor Inhibitors, Agonists, Antagonists, Activators, Modulators & Ligands

Product Name	Adenosine A₁ receptor (A₁R)	Adenosine A_2A receptor (A_2AR)	Adenosine A_2B receptor (A_2BR)	Adenosine A₃ receptor (A₃R)	Purity
Inosine	A₁AR	A_2AR			99.94%
ZM241385		A2AR, Ki: 1.4 nM			99.45%
8-(p-Sulfophenyl)theophylline			hA_2B, Ki: 1330 nM		≥98.0%
NBUMP	A₁AR, Ki: 46 nM
Adenosine 5'-monophosphate disodium			A2BR		99.92%
PSB-1115			A2BR		99.09%
Derenofylline	A1R, Ki: 1 nM	A2AR, Ki: 398 nM		Adenosine A₃ receptor, Ki: 200 nM	99.93%
DPTN dihydrochloride				hA₃, Ki: 1.65 nM	98.47%
CCPA	A₁AR, Ki: 0.4 nM				99.77%
PSB36	rA₁, Ki: 0.12 nM	rA_2A, Ki: 552 nM	hA_2B, Ki: 187 nM	hA₃, Ki: 2300 nM rA₃, Ki: 6500 nM	99.94%
FR194921	A1R, Ki: 6.6 nM	A_2AR, Ki: 5400 nM			98.10%
(E)-8-(3-Chlorostyryl)caffeine		A2AR			99.4%
MIPS521	A₁AR				98.21%
ISAM-140			hA_2B, Ki: 3.49 nM		99.13%
VUF-5574				Recombinant Human Adenosine A³ receptor (A³R) , Ki: 4.03 nM	99.0%
ANR94		A2AR, Ki: 46 nM (human)			98.91%
Adenosine receptor inhibitor 1	A₁AR, Ki: >1000 nM	A2AR, Ki: 68.5 nM	hA_2B, Ki: >1000 nM	Adenosine A₃ receptor, Ki: >1000 nM	98.29%
Evodenoson		A2AR			99.94%
2'-MeCCPA	A₁AR				99.80%
Sulcatone		A2AR			99.80%
M1069		A2AR	A2BR		99.52%
AB-MECA				Adenosine A₃ receptor	98.32%
Adenosine receptor inhibitor 2	A₁AR, Ki: 52.2 ± 8.5 nM	A2AR, Ki: 167 ± 22 nM	hA_2B, Ki: >1000 nM	Adenosine A₃ receptor, Ki: >1000 nM	99.08%
MRS1334	rA₁, Ki: >100 nM	rA_2A, Ki: >100 nM		hA₃, Ki: 2.69 nM	98.93%
LUF5834	A1R, Ki: 2.6 nM	A2AR, Ki: 28 nM	A2BR, EC₅₀: 12 nM		99.8%
MRE 0094		A_2A, Ki: 0.49 μM	A_2B, Ki: 10 μM		99.79%
Adenosine receptor antagonist 2		A2a adenosine receptor, IC₅₀: 1 nM A2b adenosine receptor, IC₅₀: 3 nM			99.37%
A1AR antagonist 6	hA₁AR, pKi: 7.13	hA_2AAR, pKi: <4			98.13%
PBF-999		A2AR			98.89%
2-Hexynyl-5′-N-ethylcarboxamidoadenosine		A2AR			99.39%
2-Hydrazinyl-adenosine		A2AR
DMPX	A₁AR, Ki: 45 μM	A2AR, Ki: 11 μM			99.66%
A2AAR antagonist 2		A2a adenosine receptor, IC₅₀: 33.5 nM			99.40%
A2A receptor antagonist 3	A1R, Ki: 107 nM	A2AR, Ki: 0.4 nM	A2BR, Ki: 37 nM	A3R, Ki: 1467 nM	99.46%
YT 146		A2AR			99.72%
A1AR antagonist 5	hA₁AR, pKi: 6.11	hA_2AAR, pKi: <4
GW-493838	A₁AR
MRS3558		hA_2AAR, Ki: 0.6 nM rA_2A, Ki: 0.9 nM
ST 1535		A2a adenosine receptor			99.80%
KF20274	A₁AR
A1AR antagonist 4	hA₁AR, pKi: 6.29	hA_2AAR, pKi: <4
PSB11 hydrochloride				human A3, Ki: 2.3 nM
BW-534U87	A₁AR
hA3AR agonist 1				Adenosine A₃ receptor, Ki: 2.40 nM
MDL-102234	A₁AR, Ki: 23.2 nM
LAS38096	A1, Ki: >1000 nM	A_2A, Ki: >2500 nM	A_2B, Ki: 17 nM	A3, Ki: >1000 nM
Adenosine receptor antagonist 5				human A3, Ki: 12 nM
FK-352	A1R
MRS542				A3, pKi: 8.76
Adenosine receptor antagonist 7	A1, Ki: 1.5 nM	A_2A, Ki: 0.6 nM	A_2B, Ki: 21 nM
LJ-4517		A2AR, Ki: 18.3 nM
A2AAR antagonist 4	hA₁AR, Ki: 286 nM	hA_2AAR, Ki: 0.36 nM hA_2AAR, Kb: 1 nM	hA_2B, Ki: 85.8 nM	hA₃, Ki: 98.4 nM
A3AR antagonist 3	hA₁AR, Ki: 2.22 μM	hA_2AAR, Ki: 7.73 μM		hA₃, Ki: 37 nM
CP-608039				Adenosine A₃ receptor
SCH-202676				Adenosine A₃ receptor	99.46%
A3AR agonist 4				human A3, Ki: 1.24 nM
A3AR modulator 1				Adenosine A₃ receptor
MK-1088	hA₁AR, Ki: 82 nM	hA_2AAR, Ki: 0.31 nM	hA_2B, Ki: 5.3 nM	hA₃, Ki: 233 nM
ATL444	rA₁, Ki: 7.0 nM	rA_2A, Ki: 2.5 nM	A2BR, Ki: 61.8 nM	rA₃, Ki: >1000 nM
MRS7469	hA₁AR, Kd: 2.14 nM
hA2A/hCA XII modulator 1	hA₁AR, Ki: 4.819 μM	hA_2AAR, Ki: 6.4 nM		hA₃, Ki: >30 μM
A2AR-antagonist-1		A2AR, IC₅₀: 29 nM
VCP171	A1R				99.18%
A2AAR/HDAC-IN-1	A₁AR, Ki: 503.3 ± 14 nM	A2AR, Ki: 163.5 ± 14 nM	hA_2B, Ki: >10000 nM	Adenosine A₃ receptor, Ki: >10000 nM
Neladenoson dalanate hydrochloride	A1R
A2A receptor antagonist 2		A2AR, IC₅₀: 8.3 nM
A2AR modulator-1		A2AR, IC₅₀: 9 nM
Adenosine receptor antagonist 6	A1, Ki: 392.23 nM		A_2B, Ki: 2129 nM	A3, Ki: 9036 nM
A3AR antagonist 1				hA₃, Ki: 4.63 nM
A3AR antagonist-7				Adenosine A₃ receptor, Ki: 31.8 nM
A3AR antagonist 2				hA₃, Ki: 4.54 nM
A2AR/A2BR antagonist 1		A2AR, IC₅₀: 11.2 nM	A2BR, IC₅₀: 6.4 nM
Neladenoson dalanate	A1R
A3AR antagonist 6	A1R, Ki: 489.3 nM	A_2AR, Ki: 364 nM	A2BR, Ki: 63.6 nM	A3R, Ki: 6.8 nM
SYAF080			hA_2B, Ki: 23.6 nM hA_2B, Kb: 25.2 nM
KT-1	A1R
MIPS3526	A₁AR, pEC₅₀: 7.08	A2AR, pEC₅₀: 6.72	A2BR, pEC₅₀: 10.24 A2BR, EC₅₀: 58 pM	A3R, pEC₅₀: 5.48
A2AAR antagonist 5	hA₁AR, Ki: > 30000 nM	hA_2AAR, IC₅₀: 1863 nM hA_2AAR, Ki: 57 nM	hA_2B, Ki: > 30000 nM	hA₃, Ki: 358 nM
Naxifylline	rat A1, Ki: 0.67 nM human A1, Ki: 0.45 nM
MRS5698				Adenosine A₃ receptor, Ki: ~3 nM
A2A/A3 AR antagonist-1		hA_2AAR, Ki: 90 nM		hA₃, Ki: 31.8 nM
A1AR antagonist 3	human A1, Ki: 9.69 nM rat A1, Ki: 0.529 nM
Adenosine receptor agonist 2			A_2B, EC₅₀: 0.38 nM
IHCH-3185		A2AR, Ki: 7.6 nM
A1/A3 AR antagonist 1	human A1, Ki: 36.7 nM rat A1, Ki: 1.47 nM			human A3, Ki: 25.4 nM
IRFI-165	rat A1, Ki: 7.9 nM				98.0%
Adenosine receptor antagonist 1		A2AR, IC₅₀: 0.29 nM
JNJ-10450232				A3R
2-Chloro-3-deazaadenosine	A1, Ki: 0.3 μM	A_2A, Ki: 0.08 μM	A_2B, Ki: 25.5 μM	A3, Ki: 1.9 μM
Benzo[c][1,8]naphthyridin-6(5H)-one	hA₁AR, Ki: 4.6 μM	hA_2AAR, Ki: 4.8 μM
CVT-2759 analog	A1, Ki: 167 nM
CVT-5440	A₁, Ki: >10,000 nM	A_2A, Ki: >5,000 nM	A_2B, Ki: 50 nM
MRS1067				Adenosine A₃ receptor
CGH2466 dihydrochloride	A₁, IC₅₀: 19 nM		A_2B, IC₅₀: 21 nM	A3, IC₅₀: 80 nM
Adenosine receptor agonist 1				hA₃, Ki: 6.7 nM
VUF8504	human A1, Ki: 14 nM			human A3, Ki: 0.017 nM
GW 328267		A2a adenosine receptor
FLAC6		A_2AR

Name
Email *

	Sorry, but the email address you supplied was invalid.